Profile picture

Professor Liqun Wu

(China)
Follow
Logo ESC

Contributor content

Cryoballoon ablation vs. antiarrhythmic drug therapy as initial treatment for persistent atrial fibrillation: <em>the multicentre randomized CEPAF trial</em>
Journal
Cryoballoon ablation vs. antiarrhythmic drug therapy as initial treatment for persistent atrial fibrillation: <em>the multicentre randomized CEPAF trial</em>
1 September 2026
See more
Senescent CD8<sup>+</sup> T cells: a novel risk factor in atrial fibrillation
Journal
Senescent CD8<sup>+</sup> T cells: a novel risk factor in atrial fibrillation
9 October 2024
See more

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources